BioWorld MedTech

Nov. 7, 2011

NewCo on the Block: CerviLenz offers screening tool for preterm birth risk

CerviLenz (Chagrin Falls, Ohio), a woman's health device company in the Cleveland area, has recently bumped its Series A round of investment up to $8.35 million, thanks to a recent tranche of funding from existing investors. Read More

Report from Europe: Ziehm Imaging reports the opening of French sales office

Spinal USA continues down path of growth with 2 recent approvals

Washington roundup: Industry urges CMS to revisit criteria for pass-through codes

Deals roundup: Siemens to acquire HIE developer MobileMD

Agreements/contracts: Bluewater enters western distribution with SurgLine

MDD's Fast Facts

NASS notebook: Medtronic Spinal launches T2 Altitude at NASS conference

Med-Tech Notes: GE Capital reports $5B in healthcare financing

Financings roundup: Tenet launches tender offer for 9% senior notes due 2015

HIT roundup: Nortec to support health IT in underserved communities

Med-Tech Notes: Study: no link between diabetes and kidney stones

Med-Tech Notes: U of Iowa to use GE 7T MRI for brain research

Product Briefs

People in the News

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 9, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

GDE4 blockade promotes remyelination, study finds

BioWorld Science

Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...